{"id":"https://openalex.org/W4390145075","doi":"https://doi.org/10.1007/s00210-023-02912-9","title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel kappa opioid receptor agonist ZYKR1: a randomized double-blind placebo-control phase 1 study in healthy adult human participants","display_name":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel kappa opioid receptor agonist ZYKR1: a randomized double-blind placebo-control phase 1 study in healthy adult human participants","publication_year":2023,"publication_date":"2023-12-23","ids":{"openalex":"https://openalex.org/W4390145075","doi":"https://doi.org/10.1007/s00210-023-02912-9","pmid":"https://pubmed.ncbi.nlm.nih.gov/38141084"},"language":"en","primary_location":{"id":"doi:10.1007/s00210-023-02912-9","doi":"https://doi.org/10.1007/s00210-023-02912-9","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00210-023-02912-9","pdf_url":null,"source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075430507","display_name":"Kevinkumar Kansagra","orcid":"https://orcid.org/0000-0001-9157-498X","observed_orcids":["https://orcid.org/0000-0001-9157-498X"]},"institutions":[{"id":"https://openalex.org/I4210132663","display_name":"Zydus Lifesciences Limited (India)","ror":"https://ror.org/03ktyvw44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210132663"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Kevinkumar A. Kansagra","raw_affiliation_strings":["Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India. kevinkumarkansagra@zyduslife.com","Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India. kevinkumarkansagra@zyduslife.com","institution_ids":["https://openalex.org/I4210132663"]},{"raw_affiliation_string":"Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India","institution_ids":["https://openalex.org/I4210132663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028794905","display_name":"Taufik Momin","orcid":"https://orcid.org/0000-0002-6258-6559","observed_orcids":["https://orcid.org/0000-0002-6258-6559"]},"institutions":[{"id":"https://openalex.org/I4405267004","display_name":"Zydus Therapeutics Inc. (United States)","ror":"https://ror.org/00s51q652","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taufik Momin","raw_affiliation_strings":["Zydus Therapeutics Inc., Pennington, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zydus Therapeutics Inc., Pennington, NJ, USA","institution_ids":["https://openalex.org/I4405267004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103750853","display_name":"Hardik B. Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132663","display_name":"Zydus Lifesciences Limited (India)","ror":"https://ror.org/03ktyvw44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210132663"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Hardik B. Patel","raw_affiliation_strings":["Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India","institution_ids":["https://openalex.org/I4210132663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036142225","display_name":"Chintan Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132663","display_name":"Zydus Lifesciences Limited (India)","ror":"https://ror.org/03ktyvw44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210132663"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Chintan Shah","raw_affiliation_strings":["Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India","institution_ids":["https://openalex.org/I4210132663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054635456","display_name":"Gordhan Parmar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132663","display_name":"Zydus Lifesciences Limited (India)","ror":"https://ror.org/03ktyvw44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210132663"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Gordhan Parmar","raw_affiliation_strings":["Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India","institution_ids":["https://openalex.org/I4210132663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089200463","display_name":"Ashok M Ghoghari","orcid":"https://orcid.org/0000-0001-6527-3833","observed_orcids":["https://orcid.org/0000-0001-6527-3833"]},"institutions":[{"id":"https://openalex.org/I4210132663","display_name":"Zydus Lifesciences Limited (India)","ror":"https://ror.org/03ktyvw44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210132663"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ashok Ghoghari","raw_affiliation_strings":["Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India","institution_ids":["https://openalex.org/I4210132663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102963245","display_name":"Harilal Patel","orcid":"https://orcid.org/0000-0003-0413-5079","observed_orcids":["https://orcid.org/0000-0003-0413-5079"]},"institutions":[{"id":"https://openalex.org/I4210132663","display_name":"Zydus Lifesciences Limited (India)","ror":"https://ror.org/03ktyvw44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210132663"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Harilal V. Patel","raw_affiliation_strings":["Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zydus Research Centre, Clinical R & D, Zydus Lifesciences Limited, Sarkhej-Bavla N. H. No. 8 A, Moraiya, Ahmedabad, 382213, Gujarat, India","institution_ids":["https://openalex.org/I4210132663"]}]},{"author_position":"last","author":{"id":null,"display_name":"Deven V. Parmar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267004","display_name":"Zydus Therapeutics Inc. (United States)","ror":"https://ror.org/00s51q652","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deven V. Parmar","raw_affiliation_strings":["Zydus Therapeutics Inc., Pennington, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zydus Therapeutics Inc., Pennington, NJ, USA","institution_ids":["https://openalex.org/I4405267004"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5075430507"],"corresponding_institution_ids":["https://openalex.org/I4210132663"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":0.0956,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.31492346,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"397","issue":"7","first_page":"4737","last_page":"4745"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9506999850273132,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9506999850273132,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.010200000368058681,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.00930000003427267,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kappa-opioid-receptor-agonists","display_name":"kappa opioid receptor agonists","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8320000171661377},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.996999979019165},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8889999985694885},{"id":"https://openalex.org/keywords/prolactin","display_name":"prolactin","score":0.8450000286102295},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.7360000014305115},{"id":"https://openalex.org/keywords/renal-excretion","display_name":"renal excretion","score":0.8479999899864197},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8240000009536743},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8773521184921265},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.810179591178894},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7835228443145752},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6758249402046204},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.6224445104598999},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6194973587989807},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5887609720230103},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5841425657272339},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5590949058532715},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.49612554907798767},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3405149579048157},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017473","descriptor_name":"Receptors, Opioid, kappa","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D053961","descriptor_name":"Azabicyclo Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s00210-023-02912-9","doi":"https://doi.org/10.1007/s00210-023-02912-9","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00210-023-02912-9","pdf_url":null,"source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},{"id":"pmid:38141084","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38141084","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's archives of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W142954314","https://openalex.org/W2028729598","https://openalex.org/W2030177235","https://openalex.org/W2036234057","https://openalex.org/W2038769057","https://openalex.org/W2084910781","https://openalex.org/W2125936469","https://openalex.org/W2136180717","https://openalex.org/W2171367696","https://openalex.org/W2317062045","https://openalex.org/W2416880829","https://openalex.org/W3004714526","https://openalex.org/W3125234912","https://openalex.org/W3162077173","https://openalex.org/W3209407069","https://openalex.org/W4224075938","https://openalex.org/W4283155225"],"related_works":["https://openalex.org/W4224075938","https://openalex.org/W4390768231","https://openalex.org/W2614287697","https://openalex.org/W2793277781","https://openalex.org/W1539388605","https://openalex.org/W4403376998","https://openalex.org/W2096568384","https://openalex.org/W4412527079","https://openalex.org/W4411495880","https://openalex.org/W1490652616"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-12-24T00:00:00"}